PRVA - Privia Health Group, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.20
DETAILS
HIGH:
$36.00
LOW:
$26.00
MEDIAN:
$31.00
CONSENSUS:
$31.20
UPSIDE:
36.90%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 2,122.8 | 1,736.4 | 1,657.7 | 1,356.7 | 966.2 | 817.1 | 786.4 | 657.6 |
| Cost of Revenue | 1,913.4 | 1,559.5 | 1,496.2 | 1,221.9 | 902.6 | 734.5 | 717.9 | 601.1 |
| Gross Profit | 209.4 | 176.9 | 161.5 | 134.8 | 63.7 | 82.6 | 68.5 | 56.5 |
| Operating Expenses | ||||||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 165.3 | 152.6 | 134.3 | 149.3 | 278.6 | 55.4 | 51.0 | 53.2 |
| Other Expenses | 9.9 | 7.3 | 6.5 | 4.6 | 2.5 | 1.8 | 1.4 | 1.1 |
| Operating Expenses | 175.2 | 159.9 | 140.9 | 153.9 | 281.1 | 57.2 | 52.4 | 54.3 |
| Operating Income | ||||||||
| Operating Income | 34.2 | 17.0 | 20.6 | (19.1) | (217.4) | 25.4 | 16.1 | 2.2 |
| Interest Expense | 0 | 0 | 0 | 0 | 1.1 | 1.9 | 6.9 | 6.4 |
| Interest Income | 9.7 | 10.9 | 8.4 | 0.5 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||
| EBITDA | 44.1 | 24.2 | 27.2 | (14.6) | (215.0) | 27.2 | 17.5 | 3.2 |
| EBIT | 34.2 | 17.0 | 20.6 | (19.1) | (217.4) | 25.4 | 16.1 | 2.2 |
| Income Before Tax | 43.9 | 27.9 | 29.0 | (18.6) | (218.5) | 23.5 | 9.2 | (4.3) |
| Income Tax Expense | 14.2 | 10.8 | 8.0 | (6.5) | (27.9) | (7.4) | 1.2 | (0.1) |
| Net Income | 22.9 | 14.4 | 23.1 | (8.6) | (188.2) | 31.2 | 8.2 | (3.0) |
| Per Share Data | ||||||||
| EPS (Basic) | 0.19 | 0.12 | 0.20 | -0.08 | -1.77 | 0.30 | 0.08 | -0.03 |
| EPS (Diluted) | 0.18 | 0.11 | 0.19 | -0.08 | -1.77 | 0.30 | 0.08 | -0.03 |
| Shares Outstanding | 122.2 | 119.4 | 116.7 | 110.7 | 107.8 | 105.7 | 105.7 | 102.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 479.7 | 491.1 | 389.5 | 348.0 | 320.6 | 84.6 | 46.9 | 39.1 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 400.9 | 316.2 | 290.8 | 189.6 | 117.4 | 99.1 | 77.3 | 71.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 30.4 | 27.5 | 20.5 | 14.4 | 0 | 0 | 0 | 0 |
| Total Current Assets | 911.0 | 834.8 | 700.8 | 552.0 | 446.7 | 190.1 | 129.6 | 115.5 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 9.3 | 6.1 | 8.9 | 11.5 | 14.1 | 4.8 | 5.6 | 0.7 |
| Goodwill | 209.8 | 141.6 | 138.7 | 126.9 | 127.9 | 118.7 | 118.7 | 118.7 |
| Intangible Assets | 215.9 | 109.8 | 107.6 | 57.4 | 59.7 | 6.0 | 6.6 | 7.3 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 21.0 | 17.1 | 8.6 | 4.7 | 4.5 | 4.5 | 9.7 | 7.4 |
| Total Non-Current Assets | 458.4 | 301.0 | 299.1 | 240.9 | 239.7 | 138.9 | 140.6 | 134.0 |
| Total Assets | 1,369.4 | 1,135.8 | 999.9 | 792.8 | 686.4 | 329.0 | 270.2 | 249.5 |
| Current Liabilities | ||||||||
| Account Payables | 8.0 | 9.8 | 7.9 | 6.7 | 3.0 | 5.2 | 0.5 | 4.7 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0.9 | 0.9 | 3.4 | 7.1 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 503.1 | 370.6 | 332.1 | 214.6 | 148.2 | 113.0 | 86.9 | 4.4 |
| Total Current Liabilities | 568.5 | 449.1 | 387.0 | 264.3 | 190.5 | 146.9 | 115.2 | 101.3 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 31.7 | 32.8 | 39.7 | 59.9 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 2.9 | 0 |
| Other Non-Current Liabilities | 2.6 | 0.2 | 0.3 | 1 | 3 | 5.6 | 4.9 | 2.3 |
| Total Non-Current Liabilities | 9.9 | 3.2 | 5.6 | 9.5 | 45.7 | 38.4 | 47.5 | 62.1 |
| Total Liabilities | 578.4 | 452.3 | 392.5 | 273.8 | 236.2 | 185.3 | 162.7 | 163.4 |
| Stockholders' Equity | ||||||||
| Common Stock | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 | 1.0 | 1.0 | 1.0 |
| Retained Earnings | (156.3) | (179.2) | (193.6) | (216.7) | (208.1) | (19.9) | (51.1) | (59.4) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 737.2 | 635.2 | 561.4 | 499.1 | 426.9 | 146.7 | 110.2 | 88.5 |
| Total Liabilities & Equity | 1,369.4 | 1,135.8 | 999.9 | 792.8 | 686.4 | 329.0 | 270.2 | 249.5 |
| Debt Metrics | ||||||||
| Total Debt | 9.5 | 5.6 | 8.3 | 11.5 | 46.5 | 33.7 | 43.1 | 67.0 |
| Net Debt | (470.2) | (485.6) | (381.2) | (336.5) | (274.1) | (51.0) | (3.8) | 27.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | 22.9 | 14.4 | 23.1 | (12.1) | (190.6) | 30.9 | 7.9 | (4.2) |
| Depreciation & Amortization | 9.9 | 7.3 | 6.5 | 4.6 | 2.5 | 1.8 | 1.4 | 1.1 |
| Stock-Based Compensation | 0 | 0 | 0 | 67.4 | 253.5 | 0.5 | 0.2 | 1.9 |
| Change in Working Capital | 44.3 | 19.5 | 8.7 | (6.4) | 18.0 | 13.4 | 13.7 | 6.5 |
| Other Non-Cash Items | 75.4 | 59.3 | 35.0 | 0.7 | 0.2 | 0.1 | 0.3 | 0.1 |
| Operating Cash Flow | 163.4 | 109.3 | 80.8 | 47.2 | 55.1 | 38.9 | 24.4 | 5.2 |
| Investing Activities | ||||||||
| Capital Expenditure | (1.2) | (5.0) | (0.1) | (0.1) | (0.5) | (0.4) | (5.7) | (0.2) |
| Acquisitions | (181.7) | (5.3) | (47.9) | 0.1 | (32.2) | 0 | 0 | 0.1 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 1.3 | 0 | 0 | (0.1) | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (181.6) | (10.3) | (48.0) | (0.1) | (32.8) | (0.4) | (5.7) | (0.2) |
| Financing Activities | ||||||||
| Net Debt Issuance | (2.5) | 0 | 0 | (33.2) | (0.9) | (0.9) | (10.9) | 15.2 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.1 | 0 | 0 | 0.1 | (9.1) | 0.1 | 0 | 0.1 |
| Financing Cash Flow | 6.7 | 2.7 | 8.7 | (19.7) | 213.7 | (0.8) | (10.9) | 15.4 |
| Cash Position | ||||||||
| Net Change in Cash | (11.5) | 101.6 | 41.5 | 27.4 | 235.9 | 37.7 | 7.8 | 20.4 |
| Cash at Beginning | 491.1 | 389.5 | 348.0 | 320.6 | 84.6 | 46.9 | 39.1 | 18.7 |
| Cash at End | 479.7 | 491.1 | 389.5 | 348.0 | 320.6 | 84.6 | 46.9 | 39.1 |
| Free Cash Flow | 162.2 | 104.3 | 80.7 | 47.1 | 54.5 | 38.5 | 18.6 | 5.0 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 2,122.8 | 1,736.4 | 1,657.7 | 1,356.7 | 966.2 | 817.1 | 786.4 | 657.6 |
| Gross Profit | 209.4 | 176.9 | 161.5 | 134.8 | 63.7 | 82.6 | 68.5 | 56.5 |
| Operating Income | 34.2 | 17.0 | 20.6 | (19.1) | (217.4) | 25.4 | 16.1 | 2.2 |
| Net Income | 22.9 | 14.4 | 23.1 | (8.6) | (188.2) | 31.2 | 8.2 | (3.0) |
| EPS (Diluted) | 0.18 | 0.11 | 0.19 | -0.08 | -1.77 | 0.30 | 0.08 | -0.03 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 479.7 | 491.1 | 389.5 | 348.0 | 320.6 | 84.6 | 46.9 | 39.1 |
| Total Assets | 1,369.4 | 1,135.8 | 999.9 | 792.8 | 686.4 | 329.0 | 270.2 | 249.5 |
| Total Debt | 9.5 | 5.6 | 8.3 | 11.5 | 46.5 | 33.7 | 43.1 | 67.0 |
| Stockholders' Equity | 737.2 | 635.2 | 561.4 | 499.1 | 426.9 | 146.7 | 110.2 | 88.5 |
| Cash Flow | ||||||||
| Operating Cash Flow | 163.4 | 109.3 | 80.8 | 47.2 | 55.1 | 38.9 | 24.4 | 5.2 |
| Capital Expenditure | (1.2) | (5.0) | (0.1) | (0.1) | (0.5) | (0.4) | (5.7) | (0.2) |
| Free Cash Flow | 162.2 | 104.3 | 80.7 | 47.1 | 54.5 | 38.5 | 18.6 | 5.0 |